[{"address1": "601 Brickell Key Drive", "address2": "Suite 1000", "city": "Miami", "state": "FL", "zip": "33131", "country": "United States", "phone": "305-203-2034", "website": "https://www.smmttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.", "fullTimeEmployees": 159, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mahkam  Zanganeh D.D.S., M.B.A.", "age": 54, "title": "Co-CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 657809, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Dame Kay Davies DBE, FRS CBE", "age": 73, "title": "Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor", "yearBorn": 1951, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 5, "overallRisk": 10, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 24.67, "open": 25.9, "dayLow": 25.9, "dayHigh": 29.99, "regularMarketPreviousClose": 24.67, "regularMarketOpen": 25.9, "regularMarketDayLow": 25.9, "regularMarketDayHigh": 29.97, "payoutRatio": 0.0, "beta": -0.46, "forwardPE": -73.42105, "volume": 7329505, "regularMarketVolume": 7328723, "averageVolume": 3897085, "averageVolume10days": 8474050, "averageDailyVolume10Day": 8474050, "bid": 27.72, "ask": 28.12, "bidSize": 35, "askSize": 35, "marketCap": 20720379904, "fiftyTwoWeekLow": 2.1, "fiftyTwoWeekHigh": 36.91, "fiftyDayAverage": 21.3533, "twoHundredDayAverage": 18.949575, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 20365514752, "profitMargins": 0.0, "floatShares": 111934608, "sharesOutstanding": 742665984, "sharesShort": 25090847, "sharesShortPriorMonth": 21221508, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.034, "heldPercentInsiders": 0.83772004, "heldPercentInstitutions": 0.12844, "shortRatio": 7.15, "shortPercentOfFloat": 0.21079999, "impliedSharesOutstanding": 742665984, "bookValue": 0.464, "priceToBook": 60.12931, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -240755008, "trailingEps": -0.34, "forwardEps": -0.38, "enterpriseToEbitda": -86.527, "52WeekChange": 5.2416105, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 27.9, "targetHighPrice": 43.92703, "targetLowPrice": 29.902485, "targetMeanPrice": 37.365013, "targetMedianPrice": 37.43814, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 361315008, "totalCashPerShare": 0.487, "ebitda": -235366000, "totalDebt": 6450000, "quickRatio": 10.36, "currentRatio": 10.63, "debtToEquity": 1.873, "returnOnAssets": -0.525, "returnOnEquity": -1.23928, "freeCashflow": -104799248, "operatingCashflow": -173140000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SMMT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1746229917, "regularMarketTime": 1746216000, "shortName": "Summit Therapeutics Inc.", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 3897085, "fiftyTwoWeekLowChange": 25.8, "fiftyTwoWeekLowChangePercent": 12.285714, "fiftyTwoWeekRange": "2.1 - 36.91", "fiftyTwoWeekHighChange": -9.01, "fiftyTwoWeekHighChangePercent": -0.24410729, "fiftyTwoWeekChangePercent": 524.1611, "earningsTimestamp": 1746129600, "earningsTimestampStart": 1746129600, "earningsTimestampEnd": 1746129600, "earningsCallTimestampStart": 1746131400, "earningsCallTimestampEnd": 1746131400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.34, "epsForward": -0.38, "epsCurrentYear": -0.30133, "priceEpsCurrentYear": -92.589516, "fiftyDayAverageChange": 6.5466995, "fiftyDayAverageChangePercent": 0.3065896, "twoHundredDayAverageChange": 8.950424, "twoHundredDayAverageChangePercent": 0.47232848, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Summit Therapeutics plc", "nameChangeDate": "2025-05-02", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1425565800000, "postMarketChangePercent": 0.182798, "postMarketPrice": 27.951, "postMarketChange": 0.0510006, "regularMarketChange": 3.2299995, "regularMarketDayRange": "25.9 - 29.97", "marketState": "CLOSED", "exchange": "NGM", "messageBoardId": "finmb_11611587", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 13.092823, "regularMarketPrice": 27.9, "longName": "Summit Therapeutics Inc.", "displayName": "Summit Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]